Literature DB >> 6734651

Reproducibility of M-mode echocardiographic assessment of left ventricular function. Significance of the temporal range of measurements.

M Kupari.   

Abstract

The aim of this study was to evaluate the reproducibility of M-mode echocardiography in sequential studies on left ventricular (LV) function. To that end, 3 to 8 serial recordings were performed on 4 groups of healthy subjects (total number, 49) within dissimilar time periods: (1) within 3 h, (2) within 24 h, (3) within 1 to 2 weeks and (4) within 14 to 18 months. The examination technique was carefully standardized and the recordings were analysed by digitization and computer assistance; the data were averaged from 5 beats on each recording. The random variation of LV transverse dimensions and performance was roughly equal in the first 3 of these studies; the mean coefficients of variation ranged from 1.2 to 1.8% for end-diastolic dimension, from 1.7 to 2.3% for end-systolic dimension, and from 2.5 to 3.6% for ejection fraction. In the long-term study the respective mean coefficients were larger: 3.2%, 3.7% and 5.5%. The coefficients of variation for estimates of stroke volume, cardiac output, and peripheral vascular resistance ranged from 4.1 to 8.4% in studies completed within 1 day or inside 1 or 2 weeks but increased to 10-15.5% in the long-term study. The beat-to-beat variability of LV dimensions and performance, as assessed in a subgroup of 11 subjects, was roughly equal in quantity to the variability observed in the long-term study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6734651     DOI: 10.1093/oxfordjournals.eurheartj.a061675

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

1.  Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.

Authors:  J M Rapola; T J Pellinen; P Koskinen; L Toivonen; M S Nieminen
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Echocardiographic and psychometric effects of amitriptyline or imipramine plus alcohol.

Authors:  C Strömberg; A Suokas; T Seppälä; M Kupari
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Reproducibility of cardiac output measurement by cross sectional and Doppler echocardiography.

Authors:  S C Robson; A Murray; I Peart; A Heads; S Hunter
Journal:  Br Heart J       Date:  1988-06

4.  Acute effects of ethanol on left ventricular diastolic function.

Authors:  M Kupari; P Koskinen; M Hynynen; M Salmenperä; M Ventilä
Journal:  Br Heart J       Date:  1990-08

5.  Effect of digoxin on the heart in normal subjects: influence of isometric exercise and autonomic blockade: a noninvasive study.

Authors:  J Partanen; J Heikkilä; T Pellinen; M S Nieminen
Journal:  Br J Clin Pharmacol       Date:  1988-03       Impact factor: 4.335

6.  Normal serial variability for M-mode and digitized echocardiography in a pediatric population.

Authors:  G G Sandor; P Schumacher; M L Puterman; R Popov
Journal:  Pediatr Cardiol       Date:  1987       Impact factor: 1.655

7.  Circadian variation of left ventricular diastolic function in healthy people.

Authors:  S Voutilainen; M Kupari; M Hippelainen; K Karppinen; M Ventila
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

8.  Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects.

Authors:  C Strömberg; A Suokas; T Seppälä
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Hemodynamic effects of the novel cardiotonic drug simendan: echocardiographic assessment in healthy volunteers.

Authors:  J M Lilleberg; S Sundberg; T Leikola-Pelho; M S Nieminen
Journal:  Cardiovasc Drugs Ther       Date:  1994-04       Impact factor: 3.727

10.  Haemodynamic dose-efficacy of levosimendan in healthy volunteers.

Authors:  J Lilleberg; S Sundberg; M Häyhä; J Akkila; M S Nieminen
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.